Cargando…

Rituximab utilization for approved and off‐label nononcology indications and patients’ experiences with the Patient Alert Card

This study used retrospective chart review and survey data to evaluate: (1) off‐label use of rituximab (MabThera(®)/Rituxan(®)) in autoimmune conditions and (2) patients’ receipt and knowledge of the Patient Alert Card (PAC), a risk minimization measure for progressive multifocal leukoencephalopathy...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sarsour, Khaled, Beckley‐Kartey, Senam, Melega, Simone, Odueyungbo, Adefowope, Kirchner, Petra, Khalife, Natasha, Bangs, Joanne
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6941895/ https://www.ncbi.nlm.nih.gov/pubmed/31911839 http://dx.doi.org/10.1002/prp2.555

Ejemplares similares

Mentoring in biostatistics: some suggestions for reform
por: Odueyungbo, Adefowope, et al.
Publicado: (2012)

US Food and Drug Administration Accelerated Approval Program for Nononcology Drug Indications Between 1992 and 2018
por: Omae, Kenji, et al.
Publicado: (2022)

Rituximab pediatric drug development: Pharmacokinetic and pharmacodynamic modeling to inform regulatory approval for rituximab treatment in patients with granulomatosis with polyangiitis or microscopic polyangiitis
por: Jamois, Candice, et al.
Publicado: (2022)

Comparison of generalized estimating equations and quadratic inference functions using data from the National Longitudinal Survey of Children and Youth (NLSCY) database
por: Odueyungbo, Adefowope, et al.
Publicado: (2008)

Histopathological Audit of 373 Nononcological Hysterectomies in a Teaching Hospital
por: Tiwana, Kanwardeep Kaur, et al.
Publicado: (2014)

Parenting-by-gender interactions in child psychopathology: attempting to address inconsistencies with a Canadian national database
por: Browne, Dillon T, et al.
Publicado: (2010)

PET/CT in nononcological lung diseases: current applications and future perspectives
por: Capitanio, Selene, et al.
Publicado: (2016)

Do Value Thresholds for Oncology Drugs Differ from Nononcology Drugs?
por: Bae, Yuna Hyo Jung, et al.
Publicado: (2014)

Alert Cards to improve awareness of an otological emergency
por: Brown, Joshua James, et al.
Publicado: (2021)

Patients with End-stage Oncologic and Nononcologic Disease in Emergency Service of an Urban Tertiary Hospital
por: Amado, Jose P, et al.
Publicado: (2018)

Risk of Malignancies in Patients with Rheumatoid Arthritis Treated with Rituximab: Analyses of Global Postmarketing Safety Data and Long-Term Clinical Trial Data
por: Emery, Paul, et al.
Publicado: (2019)

The role of antiresorptive drugs and medication-related osteonecrosis of the jaw in nononcologic immunosuppressed patients: A systematic review
por: Sacco, Roberto, et al.
Publicado: (2021)

Psychopathological and Personality Pro ﬁle in Chronic Nononcologic Nociceptive and Neuropathic pain: Cross-sectional Comparative Study
por: Teixidó-Abiol, Laura, et al.
Publicado: (2023)

Difficult airway alert card: A good deed comes around
por: Chhabra, Swati, et al.
Publicado: (2021)

Efficacy and tolerability of low-dose oral prolonged-release oxycodone/naloxone for chronic nononcological pain in older patients
por: Guerriero, Fabio, et al.
Publicado: (2014)

Corrigendum to “Different Presentation and Outcomes in the Surgical Treatment of Advanced MRONJ in Oncological and Nononcological Patients Taking or Not Corticosteroid Therapy”
por: Garzino-Demo, Paolo, et al.
Publicado: (2021)

EuCARD-2 kicks off
por: Giampietro, M
Publicado: (2013)

Rituximab in Multiple Sclerosis: Are We Ready for Regulatory Approval?
por: Brancati, Serena, et al.
Publicado: (2021)

EuCARD2 Kick-off meeting
por: Vretenar, M
Publicado: (2013)

Survival of Critically Ill Oncologic Patients Requiring Invasive Ventilatory Support: A Prospective Comparative Cohort Study With Nononcologic Patients
por: López, Rene, et al.
Publicado: (2019)

Comparison of brachial and carotid artery ultrasound for assessing extent of subclinical atherosclerosis in HIV: a prospective cohort study
por: Odueyungbo, Adefowope, et al.
Publicado: (2009)

Off-Label Uses of Rituximab in Dermatology
por: Cole, Connor, et al.
Publicado: (2022)

Evaluation of patients’ knowledge about oral anticoagulant medicines and use of alert cards by community pharmacists
por: Jani, Yogini H., et al.
Publicado: (2020)

Evaluation of Serious Infection in Pediatric Patients with Low Immunoglobulin Levels Receiving Rituximab for Granulomatosis with Polyangiitis or Microscopic Polyangiitis
por: Melega, Simone, et al.
Publicado: (2022)

Comparison of the Burden Evolution of the Family Caregivers for Patients With Cancer and Nononcological Diseases Who Need Palliative Care: A Prospective Longitudinal Study
por: Pop, Rodica Sorina, et al.
Publicado: (2023)

Incidence and complications of interstitial lung disease in users of tocilizumab, rituximab, abatacept and anti-tumor necrosis factor α agents, a retrospective cohort study
por: Curtis, Jeffrey R., et al.
Publicado: (2015)

Gait Improvement by Alerted Push-Off via Heating of Insole Tip
por: Oshita, Kazushige
Publicado: (2022)

Ciprofloxacin Use in Hospitalized Children: Approved or Off-label?
por: Faghihi, Toktam, et al.
Publicado: (2017)

Off-label use of rituximab in dermatology: pemphigus treatment
por: Bomm, Lislaine, et al.
Publicado: (2013)

Functional status in the COVID-19 era: ALERT, ALERT, ALERT!
por: Marques, A.
Publicado: (2021)

Off-label use of rituximab for systemic lupus erythematosus in Europe
por: Rydén-Aulin, Monica, et al.
Publicado: (2016)

Living off the land in space: green roads to the cosmos
por: Bangs, C, et al.
Publicado: (2007)

A secure location-based alert system with tunable privacy-performance trade-off
por: Ghinita, Gabriel, et al.
Publicado: (2020)

Rituximab: Adenovirus pneumonia following off-label use: case report
Publicado: (2021)

Implementation and Evaluation of a Standardized Non–Vitamin K Oral Anticoagulant (NOAC) Patient Safety Alert Card Across the Northern Region of England
por: Thomas, Honey, et al.
Publicado: (2020)

Caspase recruitment domain (CARD) family (CARD9, CARD10, CARD11, CARD14 and CARD15) are increased during active inflammation in patients with inflammatory bowel disease
por: Yamamoto-Furusho, Jesús K., et al.
Publicado: (2018)

Off-label use of rituximab in systemic lupus erythematosus: a systematic review
por: Murray, Eleanor, et al.
Publicado: (2010)

From EuCARD to EuCARD-2
por: Chaudron, M
Publicado: (2013)

From EuCARD to EuCARD-2
por: Chaudron, M
Publicado: (2013)

Java Card technology for Smart Cards : architecture and programmer's guide /
por: Chen, Zhiqun, 1969-
Publicado: (2000)

Cannot write session to /tmp/vufind_sessions/sess_b0pq3lliseq1me5gsuul74fb5a